EN
HI
Summary
As of 1 Oct, 2026, CORONA Remedies stock price is ₹2055.8. During the trading session, the stock has moved between an intraday low of ₹2046.90 and an intraday high of ₹2093.40. Over the last 52 weeks, CORONA Remedies has traded between ₹1336.60 and ₹2292.40.
The stock has recorded a trading volume of 3,277 shares,. Its Average Traded Price (ATP) is ₹2065.10, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2055.80.
CORONA Remedies has an upper circuit limit of ₹2512.00 and a lower circuit limit of ₹1674.80. The total value traded stands at ₹67.67 L, and the delivery percentage for the day is 49.52%.
The stock is currently traded with a market lot size of 1. CORONA Remedies also offers a dividend yield of 0.49%.
CORONA Remedies Share Price Chart
CORONA Remedies Share Key Metrics
Volume
3277.00
Market Cap
12803.25 CR
LTQ@LTP
1@2055.80
ATP
2065.1
Var Margin
13.44 %
Circuit Range
1674.8-2512
Delivery %
49.52 %
Value
67.67 L
ASM/GSM
No
Market Lot
1
CORONA Remedies Fundamentals
P/E Ratio
63.12
P/B Ratio
15.57
Div. Yield
0.49
Sector P/E
43.06
Sector P/B
3.63
Sec. Div. Yield
0.51
CORONA Remedies Resistance and Support
Pivot 2089.1
Resistance
First Resistance
2116.1
Second Resistance
2138.8
Third Resistance
2165.8
Support
First Support
2066.4
Second Support
2039.4
Third Support
2016.7
CORONA Remedies Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 01 2026 | 2093.3 | 2055.8 | -1.80% | 2093.4 | 2046.9 |
| Wed Sep 30 2026 | 2085 | 2093.39 | 0.72% | 2111.8 | 2062.1 |
| Tue Sep 29 2026 | 2053 | 2078.39 | 1.22% | 2108.19 | 2001.09 |
CORONA Remedies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-11 | Audited Results & Final Dividend |
| 2026-02-02 | Quarterly Results |
| 2026-01-02 | Quarterly Results |
CORONA Remedies News
Corona Remedies Ltd - 544644 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Corona Remedies' non-promoter group, Sepia Investments, Sage Investment Trust, and Anchor Partners, collectively sold 4.29% of the company's equity stake. The sale involved 2,629,880 shares via open market on September 10, 2026.
Sep 19 2026 15:42:04
Corona Remedies Ltd - 544644 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sepia Investments Limited, Sage Investment Trust, and Anchor Partners, acting in concert, disposed of 2.63 million shares of Corona Remedies. This transaction, executed on the National Stock Exchange on September 10, 2026, resulted in their combined shareholding decreasing by 4.29% to 9.12% of the company's total voting capital.
Sep 19 2026 15:14:30
Read More
CORONA Remedies Management
| Name | Position |
|---|---|
| Kirtikumar Laxmidas Mehta | Chairman |
| Niravkumar Kirtikumar Mehta | Managing Director & Chief Executive Officer |
CORONA Remedies Similar Stocks
Concord Biotech Ltd.
1377.20
3.60 (0.26%)
Molbio Diagnostics Ltd.
1383.30
74.40 (5.68%)
Rainbow Children's Medicare Ltd.
1292.80
-21.50 (1.64%)
Sudeep Pharma Ltd.
1207.50
1.70 (0.14%)
Akums Drugs & Pharmaceuticals Ltd.
821.00
2.50 (0.31%)
Alivus Life Sciences Ltd.
1365.40
-13.90 (1.01%)
Park Medi World Ltd.
272.35
-2.60 (0.95%)
Metropolis Healthcare Ltd.
544.05
2.35 (0.43%)
Sanofi Consumer Healthcare India Ltd.
3711.00
-91.80 (2.41%)
Strides Pharma Science Ltd.
1104.80
-15.20 (1.36%)
CORONA Remedies FAQs
The Buying Price of CORONA Remedies share is 2055.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy CORONA Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for CORONA Remedies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of CORONA Remedies shares is 63.12. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio CORONA Remedies shares is 15.57. Useful to assess the stock's value relative to its book value.
To assess CORONA Remedies’s valuation compare Sector P/E, P/B which are 43.06 & 3.63 with sector averages, along with growth rates and financial metrics.
The Market Cap of CORONA Remedies is 12803.25 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of CORONA Remedies share price is 2292.40 & 1336.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
CORONA Remedies belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in CORONA
